MAOLAC Overview
Maolac is developing a new line of novel, high impact Bio Functional Proteins (BFPs) that can be integrated into food, beverages, supplements and cosmetic products. The company's functional ingredients are based on a, proprietary Proteomics Discovery Platform (MAOreka) that enables the enrichment of specific groups of functional proteins. Through the use of AI tools, including NLP search algorithms and Web Scraping technologies, MAOreka examines a variety of functional protein sources, be they dairy or plant-based, finding the best potential protein combinations that carry a high bio-similarity to human breast milk. Coupled with a unique delivery system for improved absorption and protein stability, Maolac functional ingredients offer significantly better performance at lower dosages. The company studies all the proteins participating in these metabolic/immunological pathways by a broad literature survey and search according to keywords. Doing so, Maolac can produce new protein mixtures, which will be active and precise for any desired effect, such as anti-inflammation, gut health, and many more. MAOreka™ ensures quick (1-1.5 years) and cost-effective bioactive product releases vs. the standard R&D process, which may take over a decade and cost millions. The products are made up of two key elements – Pre-designed active protein mixtures that will give us that clear indication, and an absorption system to protect the functionality of the proteins in oral administration. Its unique methodology offers access to a stream of new BFPs (Bio Functional Proteins), each targeting a specific indication with a specific mix of active proteins. Maolac BFPs are derived either from dairy source or a plant-based one. The common theme for all - they are Human-Grade (i.e. have a high bio-similarity to human functional proteins), making them, by design, the highest performing in the market.
Cumulative Funding Raised Over Time ($)
$850KJan 2020
$4.0MMay 2022
$4.0MSep 2023
Latest News
growth-positive
Cream of the crop: Maolac wins NutraIngredients Start-up Award 2024
Maolac, a company that uses AI and deep protein intelligence to develop functional protein formulations, has won the NutraIngredients Start-up Award. The companys products, which have a high bio-similarity to human breast milk, are designed to fulfill the demand for potent and targeted nutritional supplements. Maolac was launched in 2018 and uses its proprietary AI system, Maoreka, to analyze protein combinations. The companys first products were based on targeted bovine colostrum isolates. Maolac is planning to launch a plant-based product and expand into new markets.
CustomersExpand
growth-positive
Maolac NPD: Gut support and anti-inflammatory activity targeted with AI and breastmilk
Maolac, an Israeli start-up, has launched two new products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity. These products are the result of combining breastmilk and artificial intelligence. The companys unique algorithm, Maoreka, uses computational biology and generative AI to identify specific protein combinations for specific indications. The proteins in Maolacs new products come from bovine colostrum but have high similarity to human breastmilk. The company is initially targeting the US and Europe, but aims to have a global reach.
CustomersExpand
growth-positive
Maolac leverages AI for bio-functional proteins targeting gut and immune systems
Israeli food tech company Maolac has launched two new ingredients, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, developed using the companys AI technology, Maoreka. The ingredients are bio-functional protein mixtures with benefits similar to those found in breast milk. The companys technology identifies distinct protein combinations for specific indications, allowing the creation of potent functional ingredients that can be integrated into various foods and supplements. In 2022, Maolac raised $3.2 million in seed funding to grow its portfolio.
InvestmentExpand
growth-positive
Maolac 2.0: Start-up looks to fungi and plant side streams for breast milk protein biosimilarity
Maolac, a biotechnology company founded in 2018, is leveraging AI technology to identify functional proteins in bovine colostrum that are similar to those found in human milk. The company aims to deliver the benefits of human milk, such as reduced inflammation, to the food and beverage industry. However, the company has realized that its technology can be applied to many side streams, not just bovine colostrum. The company is now looking beyond the animal realm and exploring different raw materials to create premium ingredients. Maolac is also working on its Novel Foods application in Europe and expects to launch in collaboration with a dairy major in Spain and another in Israel.
PartnersExpand
growth-positive
Maolac creating protein with breast milk-like benefits
Israeli food tech startup Maolac, which is developing a superfood by extracting proteins from bovine colostrum or plant-based analogs, has raised $3.2 million in a seed funding round led by OurCrowd. The funds will be used to build a pilot facility, create analytics and samples for customers and clinical trials, and expand the team. The company, which was founded in 2018, is working on its first product line of anti-inflammatory aids expected to hit the market in 2023. Maolac is also seeking regulatory approval in the U.S. and Europe.
InvestmentExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $4.05M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 4 |
| Investors | 9 |
Team Members
4
Employees: 11-50
Web & Social Links
| Website | maolac.com |
Locations
Tirat Carmel, Israel
Photos & Videos
1 item(s)
MAOLAC Business
Business models
B2B, B2B2C
Product stage
R&D
Employees
11-50
Sector
Agriculture & Food TechnologiesFood TechFood Trade & ServicesFood ProcessingHealth Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Agriculture & FoodProcessed FoodsIngredientsLivestockDairyCore Technology
Artificial IntelligenceNatural Language ProcessingBiologicalsMoleculesTags (12)
deep-learningpetseldersfood-ingredientsathletesnatural-language-processingfoodtechbig-datanutritionsupplementsbioinformaticsartificial-intelligenceGeographic Markets
GlobalMAOLAC Financials
$4.05M
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Seed
Funding stage
4
Total rounds
9
Investors
Cumulative Funding Raised Over Time ($)
$850KJan 2020
$4.0MMay 2022
$4.0MSep 2023
Private Equity Funding
Undisclosed Round
Sep 2023
Undisclosed
Pascual Innoventures
Seed
May 2022
$3.2M
OurCrowd (Lead)
,
theFoodTechLab, VentureIsrael, The Kitchen FoodTech Hub, Mediterranean Towers Ventures, NEOME, New Gate Capital
Undisclosed Round
Jan 2020
$850K
Undisclosed Investor(s), The Kitchen FoodTech Hub
Non-Equity Funding
GrantEvent
Sep 2024
Undisclosed
Israel Innovation Authority
MAOLAC Lifecycle
Cumulative Funding Raised Over Time
$850KJan 2020
$4.0MMay 2022
$4.0MSep 2023
All Events
Undisclosed Round
Sep 2023
Undisclosed
Pascual Innoventures
Seed
May 2022
$3.2M
OurCrowd (Lead)
,
theFoodTechLab, VentureIsrael, The Kitchen FoodTech Hub, Mediterranean Towers Ventures, NEOME, New Gate Capital
Undisclosed Round
Jan 2020
$850K
Undisclosed Investor(s), The Kitchen FoodTech Hub
GrantEvent
Sep 2024
Undisclosed
Israel Innovation Authority
MAOLAC News
10 articles
growth-positive
Cream of the crop: Maolac wins NutraIngredients Start-up Award 2024
Maolac, a company that uses AI and deep protein intelligence to develop functional protein formulations, has won the NutraIngredients Start-up Award. The companys products, which have a high bio-similarity to human breast milk, are designed to fulfill the demand for potent and targeted nutritional supplements. Maolac was launched in 2018 and uses its proprietary AI system, Maoreka, to analyze protein combinations. The companys first products were based on targeted bovine colostrum isolates. Maolac is planning to launch a plant-based product and expand into new markets.
CustomersExpand
growth-positive
Maolac NPD: Gut support and anti-inflammatory activity targeted with AI and breastmilk
Maolac, an Israeli start-up, has launched two new products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity. These products are the result of combining breastmilk and artificial intelligence. The companys unique algorithm, Maoreka, uses computational biology and generative AI to identify specific protein combinations for specific indications. The proteins in Maolacs new products come from bovine colostrum but have high similarity to human breastmilk. The company is initially targeting the US and Europe, but aims to have a global reach.
CustomersExpand
growth-positive
Maolac leverages AI for bio-functional proteins targeting gut and immune systems
Israeli food tech company Maolac has launched two new ingredients, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, developed using the companys AI technology, Maoreka. The ingredients are bio-functional protein mixtures with benefits similar to those found in breast milk. The companys technology identifies distinct protein combinations for specific indications, allowing the creation of potent functional ingredients that can be integrated into various foods and supplements. In 2022, Maolac raised $3.2 million in seed funding to grow its portfolio.
InvestmentExpand
growth-positive
Maolac 2.0: Start-up looks to fungi and plant side streams for breast milk protein biosimilarity
Maolac, a biotechnology company founded in 2018, is leveraging AI technology to identify functional proteins in bovine colostrum that are similar to those found in human milk. The company aims to deliver the benefits of human milk, such as reduced inflammation, to the food and beverage industry. However, the company has realized that its technology can be applied to many side streams, not just bovine colostrum. The company is now looking beyond the animal realm and exploring different raw materials to create premium ingredients. Maolac is also working on its Novel Foods application in Europe and expects to launch in collaboration with a dairy major in Spain and another in Israel.
PartnersExpand
growth-positive
Maolac creating protein with breast milk-like benefits
Israeli food tech startup Maolac, which is developing a superfood by extracting proteins from bovine colostrum or plant-based analogs, has raised $3.2 million in a seed funding round led by OurCrowd. The funds will be used to build a pilot facility, create analytics and samples for customers and clinical trials, and expand the team. The company, which was founded in 2018, is working on its first product line of anti-inflammatory aids expected to hit the market in 2023. Maolac is also seeking regulatory approval in the U.S. and Europe.
InvestmentExpand
growth-positive
Foodtech startup Maolac raises $3.2 million Seed round to create superfood with the health benefits of breast milk | CTech
Israeli foodtech startup Maolac has raised $3.2 million in a seed funding round to develop its proteomics discovery platform. The company uses this technology to create an anti-inflammatory product line aimed at reducing muscle strain in athletes and improving the mobility of the elderly. The funding round was led by OurCrowd and included participation from The Kitchen FoodTech Hub, The Food Tech Lab, VentureIsrael, NEOME, and Mediterranean Towers Ventures. Maolac plans to use the funding to build a state-of-the-art facility for small-scale production and analytics.
InvestmentExpand
growth-positive
קרן השקעות הדיור המוגן משקיעה בפודטק, וזה הסכום
Mediterranean Towers Ventures, an investment fund specializing in AgeTech, has invested $350,000 in food-tech startup Maolac. The startup has completed a funding round of $3.242 million. Maolac develops bio-functional proteins that have health benefits, particularly for the elderly population. The company uses computational biology to develop mixtures from bovine colostrum, which can strengthen the immune system and provide active and targeted protection to the body. The proteins developed by Maolac can enrich and integrate with a large number of foods, food supplements, and even care products.
Investment
growth-positive
Start-up 'cracks the breast milk code' to make human milk proteins for everyone, not just babies
Maolac, a company co-founded by Maya Ashkenazi, is developing a product that replicates the beneficial proteins found in human breast milk. The product is made from upcycled bovine colostrum and is intended to have applications in multiple markets, including infant nutrition, sports nutrition, healthy aging, and pet and livestock care. The companys initial focus is on sports nutrition, with the aim of reducing inflammation and improving recovery time in athletes. Maolacs first product is expected to be ready for market by Q1 2023.
CustomersPartnersExpand
growth-positive
מאיה אוטמזגין אשכנזי - Forbes 30 Under 30
MaoLac, an Israeli food-tech company, is developing a technology that extracts protein from colostrum, the first form of milk produced by mammals. The companys technology combines isolation and separation of proteins from colostrum using computational biology algorithms. The extracted proteins can be used in various food products, contributing to healthier and more balanced nutrition. MaoLac is planning to raise additional funding at a valuation of $10 million.
Investment
Neutral
Forbes' Young Leaders 'Under 30' Are Defining The Future Of Israel In 2020
Forbes Israel has released its annual Under 30 list for 2020, highlighting 60 young Israeli leaders in various fields. The list includes entrepreneurs, researchers, venture capitalists, social activists, actors, athletes, directors, musicians, and founders of various companies. The list also includes an entire section of 30Under30 Tech, with founders and entrepreneurs from some of the most promising startups in the Israeli high-tech ecosystem. The list is Forbes Israel’s fifth list of promising young people, a project the Israeli publication started four years ago.
None
MAOLAC Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 23 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 16 classification IDs that could be used for matching.
MAOLAC Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Ortal Wein |
| Registrar ID | 515929057 |
| Crunchbase | maolac |
| Creator | Maya Ashkenazi Otmazgin |
| Creator email | mayaotmaz1@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-12-28T00:00:00.000Z |
| Created | 2019-12-15T00:00:00.000Z |
| Claimed | Yes |